6704 Share Price Performance
NT$24.60
3.15 (14.69%)
Price NT$24.60
Share Pricen/a
Gwo Xi Stem Cell Applied Technology Co. , Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6704 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Gwo Xi Stem Cell Applied Technology Co. , Ltd Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.84
- 70.56%
- -43.05%
- 55.3%
About 6704
- Founded
- 2011
- Employees
- n/a
- CEO
- WebsiteView website
Gwo Xi Stem Cell Applied Technology Co. , Ltd develops stem cell technology for patients with unmet medical needs. Its products under development include GXHPC1, an autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of liver cirrhosis; and GXNPC1, an autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of chronic stroke. The company is also developing GXCPC1, an allogeneic adipose-derived stem cells therapy in phase I/II clinical trials for use in the treatment of osteoarthritis; and GXIPC1, an allogeneic adipose-derived stem cells therapy in phase I clinical trials for use in the treatment of diabetes. The company was founded in 2011 and is based in Zhubei, Taiwan.
